Guggenheim Upgrades Guardant Health to Buy, Announces $36 Price Target
Guardant Health +8.24% Pre
Guardant Health GH | 22.20 22.20 | +8.24% 0.00% Pre |
Guggenheim analyst Subbu Nambi upgrades Guardant Health (NASDAQ:
GH) from Neutral to Buy and announces $36 price target.